Publications Office of the EU
Radiopharmaceutical PET/CT Ålesund Hospital - Helse Møre og Romsdal HF - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Radiopharmaceutical PET/CT Ålesund Hospital - Helse Møre og Romsdal HF

  • Today
    15/05/2026
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
SYKEHUSINNKJØP HF
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33694000 Diagnostic agents
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Tender reference number
2025/57683
Description

Helse Møre og Romsdal HF, Ålesund Hospital has, since mid December 2021, run an offer with PET/CT. PET/CT is the most advanced image diagnostic examination method currently available. In order to carry out this survey, a radioactive preparation must be procured. There is currently only one commercial manufacturer in Norway, and due to its short shelf life/half-time, the products must be delivered on the same day it shall be used. Ålesund Hospital is dependent on deliveries of FDG on average 2-3 times a week with delivery by 10:00. GE Healthcare, which is located in Oslo, is the only supplier of FDG in Norway. The preparation SteriPET is a radioactive preparation with half the time, 110 minutes. The preparation ́s shelf life is 10 hours from the completed synthesis. In addition GE Healthcare produces 2 batches per day and quality assures the first delivery parallel to transporting it to the hospital. This ensures timely delivery. If batch no. 1 does not go through quality control, batch no. 2 will be at the hospital before 10:00.The total value of the procurement is estimated to be approx. The contracting authority will not enter into a contract with GE Healthcare AS until 1.11.25 At the earliest, Helse Møre og Romsdal HF (Ålesund Hospital) would like to carry out a direct procurement with GE in order to establish a framework agreement for the delivery of PET tracers as defined below, after a prior intention notice based on the argumentation above. The framework agreement will be valid for 1 year, as well as an option for a 1+1+1 year extension. Relevant products: 18F-2' – fluoro-2'-deoxyglukose (FDG)PSMA-1007 (18F) The procurement is located outside the scope of the procurement regulations. Reasons for awarding a contract without a competition notice: Based on market surveys, there is only one specific tenderer on the market in the EU/EEA who offers FDG within the given frameworks. The contracting authority therefore believes that it is necessary to enter into a contract without a competition in accordance with the procurement regulations § 13-4 first section, letter b no. 2.

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Buyers
Helse Møre og Romsdal HF
Place of performance
Award method
Not available
Estimated value
Not available
Final contracted value
Not available
Award of contract
Not available
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.